SCHEMBL6013580

SCHEMBL6013580

CNS(=O)(=O)NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16455 0.82 LMNA (0.41)
Hydrochloric Acid SCHEMBL28869556 0.77 TSHR (0.37)
SCHEMBL2053410 0.74
Guanidine SCHEMBL28078381 0.74 TSHR (0.35)
SCHEMBL10154892 0.74
SCHEMBL10155578 0.72 KMT2A (0.32)
SCHEMBL12478213 0.72 CA1 (0.39)
SCHEMBL1751607 0.71
SCHEMBL12616464 0.70 CA14 (0.37)
SCHEMBL8781705 0.70 MEN1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323066-A1 MEK INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2024-02-21 EP disclosed
CN-117580835-A MEK inhibitors and uses thereof 医肯纳肿瘤学公司 2024-02-20 CN disclosed
WO-2022221866-A1 MEK INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-10-20 WO disclosed
US-7074743-B1 Herbicidal composition comprising 4-iodo-2-[3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)ureidosulfonyl]benzoic esters HOECHST SCHERING AGREVO GMBH (DE) 2006-07-11 US disclosed